Altasciences Completes Bioanalytical Laboratory Expansion
LAVAL, QC, Canada (November 8, 2018) — Altasciences is excited to announce the completion of their laboratory expansion. The additional space will be dedicated to ligand binding and cell-based assays. Altasciences’ bioanalytical services continue to grow, and the added, state-of-the-art lab area ensures capacity to continue delivering quality bioanalysis solutions to both their preclinical and clinical clients.
The new, larger space, opened for use this week, is fully equipped to respond to increased demand for cell-based neutralization and functional assays for biologics and vaccines. Altasciences now has additional capacity for cell lineage and functional immuno-phenotyping by flow cytometry to support both preclinical and clinical studies.
“The extension of our bioanalytical laboratory ensures that we are equipped to continue providing the excellent bioanalytical services that Altasciences is known for. As demand for our services grows, we are committed to expanding our infrastructure and ensuring our usual, on-time delivery.” stated Marie-Hélène Raigneau, Altasciences’ Executive Vice President, Research Services.
Altasciences’ bioanalytical team consists of more than 100 dedicated scientists in both the U.S. and Canada who provide a comprehensive suite of bioanalytical services, from discovery to preclinical to phase IV clinical support, for both small and large molecules including immunogenicity, biomarker, and PK.
Altasciences is a contract research organization with a unique focus on supporting drug development from lead candidate selection to proof of concept. Altasciences encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, Algorithme Pharma USA in Fargo, ND, and Altasciences Preclinical Services in Seattle, WA. With over 25 years of industry experience, Altasciences provides preclinical and clinical solutions to an international customer base of biopharmaceutical companies. Altasciences’ full-service solutions offering in this critical stage of drug development includes preclinical safety testing, clinical pharmacology services, bioanalysis, medical writing, biostatistics, data management, and overall program management.
For more information